Dymension 2D Gel Analysis Software used at Specialist Institute
News Feb 22, 2008
Syngene has announced, Dymension, its software for the analysis of 2D protein gels is being used at the Open Mind Institute (OMI) in Slovenia, a new centre for studying the effects of medicinal plants, to determine the effects the anti-addictive alkaloid, ibogaine have on the brain.
Researchers in the OMI in collaboration with scientists at the University of Ljubljana in Slovenia are using Dymension to determine any post ibogaine treatment differences in silver stained rat brain proteins run on 2D gels.
The protein profiles are used to establish which proteins are up or down-regulated. This research could lead to a better understanding of the pharmacodynamics of anti-addiction therapies.
Dr Roman Paskulin, Director of the OMI explained: “We are relatively new to proteomic analysis so we chose to install Dymension software because we want to rapidly perform complicated analysis, and of the software packages we reviewed, this was visually easier to navigate and simpler for everyone to use.”
Dr Paskulin added: “Using Dymension to analyse our 2D gel images in association with MALDI-TOF on the resulting protein spots, we have seen increases in four metabolic enzymes after ibogaine treatment and are now looking at the significance of these findings.”
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Computer Program Helps Find Ways to Repurpose Existing DrugsNews
Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.READ MORE